The FDA does not review or approve compounded medications, including Tirzepatide+, for safety, effectiveness, or quality
Many patients find that weight loss injections cause minimal discomfort, often described as a brief pinch or sting lasting only seconds
Stratified management: for those with a BMI 35 kg/m 2 and significant metabolic derangement, GLP-1RAs should be integrated as a long-term management option across the reproductive life cycle
It is important to understand that while we offer compounded medications, these specific formulations are not FDA-approved in the same way a brand-name drug is, though the pharmacies that create them must be FDA-registered and inspected
For tirzepatide, hydrolysis at critical positions can completely inactivate the molecule by disrupting the binding interface that interacts with GIP and GLP-1 receptors